Anti-biofilm activity of chitosan gels formulated with silver nanoparticles and their cytotoxic effect on human fibroblasts.

The development of multi-species biofilms in chronic wounds is a serious health problem that primarily generates strong resistance mechanisms to antimicrobial therapy. The use of silver nanoparticles (AgNPs) as a broad-spectrum antimicrobial agent has been studied previously. However, their cytotoxic effects limit its use within the medical area. The purpose of this study was to evaluate the anti-biofilm capacity of chitosan gel formulations loaded with AgNPs, using silver sulfadiazine (SSD) as a standard treatment, on strains of clinical isolates, as well as their cytotoxic effect on human primary fibroblasts. Multi-species biofilm of Staphylococcus aureus oxacillin resistant (MRSA) and Pseudomonas aeruginosa obtained from a patient with chronic wound infection were carried out using a standard Drip Flow Reactor (DFR) under conditions that mimic the flow of nutrients in the human skin. Anti-biofilm activity of chitosan gels and SSD showed a log-reduction of 6.0 for MRSA when chitosan gel with AgNPs at a concentration of 100 ppm was used, however it was necessary to increase the concentration of the chitosan gel with AgNPs to 1000 ppm to get a log-reduction of 3.3, while the SSD showed a total reduction of both bacteria in comparison with the negative control. The biocompatibility evaluation on primary fibroblasts showed better results when the chitosan gels with AgNPs were tested even in the high concentration, in contrast with SSD, which killed all the primary fibroblasts. In conclusion, chitosan gel formulations loaded with AgNPs effectively prevent the formation of biofilm and kill bacteria in established biofilm, which suggest that chitosan gels with AgNPs could be used for prevention and treatment of infections in chronic wounds. The statistic significance of the biocompatibility of chitosan gel formulations loaded with AgNPs represents an advance; however further research and development are necessary to translate this technology into therapeutic and preventive strategies.

[1]  J. Loyola-Rodríguez,et al.  Bactericide efficiency of a combination of chitosan gel with silver nanoparticles , 2013 .

[2]  Tom Coenye,et al.  In vitro and in vivo model systems to study microbial biofilm formation. , 2010, Journal of microbiological methods.

[3]  Seung-Heon Shin,et al.  The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. , 2007, International immunopharmacology.

[4]  M. Ahamed,et al.  Silver nanoparticle applications and human health. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[5]  X. Chen,et al.  Nanosilver: a nanoproduct in medical application. , 2008, Toxicology letters.

[6]  Sureshbabu Ram Kumar Pandian,et al.  Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. , 2010, Colloids and surfaces. B, Biointerfaces.

[7]  R. Kimble,et al.  Cytotoxicity testing of burn wound dressings, ointments and creams: a method using polycarbonate cell culture inserts on a cell culture system. , 2011, Burns : journal of the International Society for Burn Injuries.

[8]  Lindsey A. Lorenz,et al.  A method for growing a biofilm under low shear at the air–liquid interface using the drip flow biofilm reactor , 2009, Nature Protocols.

[9]  J. Costerton,et al.  Current concepts regarding the effect of wound microbial ecology and biofilms on wound healing. , 2010, The Surgical clinics of North America.

[10]  O. Stojadinović,et al.  Interactions of Methicillin Resistant Staphylococcus aureus USA300 and Pseudomonas aeruginosa in Polymicrobial Wound Infection , 2013, PloS one.

[11]  G. Pugliese,et al.  Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Infection Control & Hospital Epidemiology.

[12]  Gregory Morose,et al.  The 5 principles of “Design for Safer Nanotechnology” , 2010 .

[13]  M. Hamilton,et al.  Development of a standardized antibiofilm test. , 2001, Methods in enzymology.

[14]  K. Paknikar,et al.  Cellular responses induced by silver nanoparticles: In vitro studies. , 2008, Toxicology letters.

[15]  Facundo Ruiz,et al.  Antibacterial effect of silver nanoparticles against Streptococcus mutans , 2009 .

[16]  Michael S. Roberts,et al.  Modeling the human skin barrier--towards a better understanding of dermal absorption. , 2013, Advanced drug delivery reviews.

[17]  P. Stewart,et al.  Development and application of a polymicrobial, in vitro, wound biofilm model , 2012, Journal of applied microbiology.

[18]  R. Jayakumar,et al.  Chitosan for Biomaterials II , 2011 .

[19]  Federica Chiellini,et al.  Chitosan—A versatile semi-synthetic polymer in biomedical applications , 2011 .

[20]  O. Mertins,et al.  Chitosan as Stabilizer and Carrier of Natural Based Nanostructures , 2011 .

[21]  C. Jérôme,et al.  Chitosan-based biomaterials for tissue engineering , 2013 .

[22]  M. Rai,et al.  Silver nanoparticles as a new generation of antimicrobials. , 2009, Biotechnology advances.

[23]  P. Tam,et al.  Silver nanoparticles: partial oxidation and antibacterial activities , 2007, JBIC Journal of Biological Inorganic Chemistry.

[24]  S. Percival,et al.  Clinical and Antibiofilm Efficacy of Antimicrobial Hydrogels. , 2014, Advances in wound care.

[25]  C. Barbante,et al.  Characterization and evaluation of silver release from four different dressings used in burns care. , 2012, Burns : journal of the International Society for Burn Injuries.

[26]  Prof. M.R Shakibaie,et al.  Anti-biofilm activity of biogenic selenium nanoparticles and selenium dioxide against clinical isolates of Staphylococcus aureus, Pseudomonas aeruginosa, and Proteus mirabilis. , 2015, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[27]  J. Santamaría,et al.  Preparation and characterization of chitosan–silver nanocomposite films and their antibacterial activity against Staphylococcus aureus , 2013, Nanotechnology.

[28]  S. Prabhu,et al.  Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects , 2012, International Nano Letters.

[29]  J. Zenilman,et al.  Molecular microbiology: new dimensions for cutaneous biology and wound healing. , 2010, The Journal of investigative dermatology.

[30]  Miqin Zhang,et al.  Chitosan-based hydrogels for controlled, localized drug delivery. , 2010, Advanced drug delivery reviews.

[31]  G. James,et al.  Anti-biofilm activity of silver nanoparticles against different microorganisms , 2013, Biofouling.

[32]  D. Hung,et al.  Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response , 2013, Virulence.

[33]  Ming Kong,et al.  Antimicrobial properties of chitosan and mode of action: a state of the art review. , 2010, International journal of food microbiology.

[34]  Benjamin A Lipsky,et al.  Biofilms and Wounds: An Overview of the Evidence. , 2015, Advances in wound care.

[35]  G. James,et al.  Silver nanoparticles with antimicrobial activities against Streptococcus mutans and their cytotoxic effect. , 2015, Materials science & engineering. C, Materials for biological applications.

[36]  P. Stewart,et al.  Testing wound dressings using an in vitro wound model. , 2010, Journal of wound care.

[37]  Claus-Michael Lehr,et al.  Modeling the human skin barrier--towards a better understanding of dermal absorption. , 2013, Advanced drug delivery reviews.

[38]  Jintae Lee,et al.  ZnO nanoparticles inhibit Pseudomonas aeruginosa biofilm formation and virulence factor production. , 2014, Microbiological research.

[39]  Z. Aziz,et al.  A systematic review of silver-containing dressings and topical silver agents (used with dressings) for burn wounds. , 2012, Burns : journal of the International Society for Burn Injuries.

[40]  Eunseog Youn,et al.  A Comparison of Bacterial Composition in Diabetic Ulcers and Contralateral Intact Skin , 2010, The open microbiology journal.

[41]  M. Hamilton,et al.  Statistical assessment of a laboratory method for growing biofilms. , 2005, Microbiology.

[42]  B. Sreedhar,et al.  Fabrication of porous chitosan films impregnated with silver nanoparticles: a facile approach for superior antibacterial application. , 2010, Colloids and surfaces. B, Biointerfaces.